Ulf Wiinberg resigns as CEO of Lundbeck Valby, Copenhagen,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Ulf Wiinberg resigns as CEO of Lundbeck

Valby, Copenhagen, 2014-11-24 08:56 CET (GLOBE NEWSWIRE) --

  • Ulf Wiinberg has informed Lundbeck’s Board of Directors that he is resigning as Chief Executive Officer with immediate effect
  • The resignation is a consequence of Ulf Wiinberg breaching the company’s Code of Conduct
  • The process of finding a replacement for Ulf Wiinberg will commence immediately. Until this process is completed, Håkan Björklund will be Chairman of the Board with extended operational responsibilities, and will in this role act as day-to-day leader of the company

Valby, Denmark, 24 November 2014 - H. Lundbeck A/S (Lundbeck) has today announced that President and CEO Ulf Wiinberg at his own request has resigned with immediate effect. 

Ulf Wiinberg’s resignation is due to the fact that, in 2013, Ulf Wiinberg omitted to request and obtain prior approval from Lundbeck’s Board of Directors to receive shares in the biotech company Stratified Medical Ltd. from the company’s founder. This is a breach of Lundbeck’s Code of Conduct, which sets the rules for the conduct of management and employees. It is an aggravating circumstance that the shares in question were in a company in which Lundbeck later invested around DKK 19 million.

Ulf Wiinberg has informed, acknowledged and apologized to the Chairman of the Board of Directors, Håkan Björklund, for this error which the Board of Directors considers a serious breach of Lundbeck’s Code of Conduct.   As a consequence, Ulf Wiinberg has informed the Board of Directors of his wish to resign from his position. The Board of Directors appreciates Ulf Wiinberg’s decision and, as matters stand, finds it appropriate.

”The Board acknowledges Ulf Wiinberg’s considerable contributions since his appointment in 2008. Ulf Wiinberg has not only acknowledged but also apologized for his erroneous actions, but this does not change the fact that Lundbeck has a clear and unmistakable Code of Conduct for all employees. We cannot operate with degrees of compliance with our Code of Conduct and the Board of Directors therefore concurs with Ulf Wiinberg’s decision to resign,” says Håkan Björklund. 

”I am sincerely sorry for the course of events, which on my part was unintentional, and of which I myself informed Håkan Björklund. I am extremely happy about my time at Lundbeck and I am proud of having taken part in the development and strengthening of the company. However, based on these events, I have found it in both parties’ best interests that I resign from my position today,” says Ulf Wiinberg.

A search for Ulf Wiinberg’s replacement will be initiated immediately. Until this process has been completed, the Chairman of the Board of Directors, Håkan Björklund, will be Chairman with extended operational responsibilities and will in this role act as day-to-day leader of the company. 

Håkan Björklund has more than 30 years of experience from the pharmaceutical industry, most notably from his time as President and CEO of Nycomed from 1999 to 2011. He has been on Lundbeck’s Board of Directors since 2011 and therefore has in-depth knowledge of the company.                                                                

Conference call

Today at 10:00 CET, Lundbeck will be hosting a conference call for the financial community. You can listen to the call online at www.lundbeck.com under the investor section or use dial-ins below:

DK:  +45 3544 5583 , UK  +44 203 194 0544 or US  +1 855 269 2604 .

Lundbeck contacts

Investors: Media:
   
Palle Holm Olesen Mads Kronborg
Vice President, Investor Relations Media Relations
PALO@lundbeck.com MAVK@lundbeck.com
+45 36 43 24 26 +45 36 43 30  00
   
Jens Høyer  
Specialist, Investor Relations  
JSHR@lundbeck.com  
+45 36 43 33 86  
     

About Lundbeck

H. Lundbeck A/S (LUN.CO, LUN DC, HLUYY) is a global pharmaceutical company specialized in brain diseases. For more than 50 years, we have been at the forefront of research within neuroscience. Our key areas of focus are alcohol dependence, Alzheimer’s disease, bipolar disorder, depression/anxiety, epilepsy, Huntington’s disease, Parkinson’s disease, schizophrenia, stroke and symptomatic neurogenic orthostatic hypotension (NOH).

An estimated 700 million people worldwide are living with brain disease and far too many suffer due to inadequate treatment, discrimination, a reduced number of working days, early retirement and other unnecessary consequences. Every day, we strive for improved treatment and a better life for people living with brain disease – we call this Progress in Mind.

Read more at www.lundbeck.com/global/about-us/progress-in-mind .

Our approximately 6,000 employees in 57 countries are engaged in the entire value chain throughout research, development, production, marketing and sales. Our pipeline consists of several late-stage development programmes and our products are available in more 100 countries. We have research centres in China, Denmark and the United States and production facilities in China, Denmark, France and Italy. Lundbeck generated revenue of approximately DKK15.3 billion in 2013 (EUR2.1 billion; USD2.7 billion).

Lundbeck’s shares are listed on the stock exchange in Copenhagen under the symbol ”LUN”. Lundbeck has a sponsored Level 1 ADR program listed in the US (OTC) under the symbol ”HLUYY”. For additional information, we encourage you to visit our corporate site www.lundbeck.com .

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vail’s Board Fight Puts Strategy Under a Sharp Lens

Updated Category News Views 62

Fresh snow does not make a boardroom dispute disappear. Vail Resorts has put out an investor presentation ahead of its December 14, 2026 annual meeting, asking shareholders to support all nine of management’s director nominees on its white proxy card. That is the formal message. The real message is plainer: NYSE:MTN knows this election has become a test of whether...

Continue Reading
Color Me Mine Tests Florida's Creative Leisure Demand

Updated Category News Views 72

Pottery studios are not exactly the sort of thing that makes markets pound the table, but Florida’s latest Color Me Mine push deserves a closer look. The company signed three franchise agreements in 2026 for Panama City Beach, Doral and Boca Raton, adding planned growth to a state where it already operates 11 studios. For a private franchisor, this is not a quarterly...

Continue Reading
Peptide Labels Cannot Substitute for Clinical Care

Updated Category News Views 151

A Label Is Not a Care Plan Those three little words, research use only, carry far more weight than a flashy product page would have people believe. The HelloNation article featuring wellness expert Andres Giraldo makes a plain but necessary distinction: a research-use-only, or RUO, label does not turn a peptide into prescribed treatment, and it sure does not establish...

Continue Reading
Somerville’s New Immersive Bet Has Room to Grow Locally

Updated Category News Views 74

A passcard, a hidden door, and 12,000 square feet of mischief have landed at Somernova. Edge of Elsewhere, the new flagship attraction from Boston-area creative studio Midnight Mansion, is open in Somerville’s Union Square as of November 18, 2026. It is part interactive art installation, part puzzle game, part physical story world. That sounds delightfully odd, which is...

Continue Reading
Watson Motion Tests Military Pretrial Confinement Rules

Updated Category News Views 170

Military confinement fights are rarely neat, and this one comes with a short clock but plenty of unanswered questions. Defense lawyers for U.S. Air Force Maj. Jason Watson argued on Nov. 17 that he should be released from pretrial confinement while his case proceeds. A military judge is ordinarily expected to issue a ruling within 14 days of the hearing, under the court's...

Continue Reading
AI Gives CPA Firms a New Advisory Staffing Math Today

Updated Category News Views 75

Month-end just got a lot less comfortable for firms living on the clock. Netsurit and Southwestern Talent are pitching the Virtual CFO Platform as a way for CPA firms to turn machine-led analysis into advisory work without first building a costly bench of specialists. That is not a cute workflow tweak. It goes straight at the labor model that has kept plenty of accounting...

Continue Reading
Hanmi Compressor Tests Vietnam Before Wider Expansion

Updated Category News Views 175

Compressed air is the sort of factory necessity nobody brags about until it fails, and that is precisely why Hanmi Compressor’s Vietnam plan deserves a sober look. The Daegu-based specialist is not arriving with a grand export victory lap. It is still building the front door: a website, a promotional video, and a process for finding Vietnamese manufacturers and...

Continue Reading
Hitachi's Quiet Fusion Bet Is Really About Data Control

Updated Category News Views 69

Weeks of engineering work can vanish because one storage system hiccups, which is a rotten way to learn that data infrastructure belongs in the mission-critical column. Esteyco’s new environment, built with Hitachi Vantara and implemented by Quadrics Sistemas, is not a fusion breakthrough. It is the less glamorous machinery that keeps serious fusion research from...

Continue Reading
Emaar's Huspy Deal Brings Financing Into Home Sales

Updated Category News Views 87

Mortgage paperwork is nobody’s idea of luxury, yet it can wreck a property sale faster than a bad floor plan. Emaar Properties has partnered with Dubai-based Huspy to give its customers access to mortgage advice and financing comparisons from more than 20 UAE banks. It is not a flashy tower launch or a headline-grabbing land purchase. Frankly, that is why investors...

Continue Reading
RayNeo's Black Friday Push Tests Smart Glasses Demand

Updated Category News Views 160

A million shipped pairs is a real milestone, but holiday markdowns are where the rubber meets the road for RayNeo. The company is taking its XR gaming glasses and iO AI smart glasses into Europe’s Black Friday scrum with discounts running through late November, betting that portability, giant virtual screens and a little AI convenience can pry open consumers’ wallets....

Continue Reading

Top 5 Most Recently Viewed Articles

How the Bank of England's Interest Rate Decision Impacts Your Investments

Updated Category Economy Views 316

Introduction The Bank of England's decision on interest rates plays a critical role in shaping the economic landscape, with far-reaching effects on your investment portfolio. Changes in these rates can influence stock market performance, affect bond yields, and alter the attractiveness of various asset classes. Understanding how these adjustments can impact your...

Continue Reading
Eric Beightel Joins Environmental Science Associates Team

Updated Category News Views 131

Eric Beightel Appointed as Federal Strategy Director Environmental Science Associates (ESA) is thrilled to welcome Eric Beightel to its team as the new Federal Strategy Director. With a comprehensive background in environmental policy, Beightel brings a wealth of knowledge to ESA, poised to enhance its capabilities in navigating the complexities of federal regulations....

Continue Reading
iBio Inc. Showcases Innovative Antibody Developments Soon

Updated Category News Views 257

Exciting Presentations from iBio Inc. iBio, Inc. (NASDAQ: IBIO), a pioneering biotechnology company, is gearing up to present breakthrough research on its Activin E antibody. This development showcases its commitment to addressing critical health challenges like obesity. Recently, Cory Schwartz, Ph.D., the Director of Research and Early Development at iBio, announced his...

Continue Reading
Turkey's Markets Experience A Dip as Investors React

Updated Category News Views 319

A Dip in Turkey's Stock Market Performance Turkey's stock market witnessed a decline recently, with shares closing lower on the exchange. The BIST 100 index, a benchmark for investors, finished down by 0.60%, indicating a challenging trading day for stakeholders. Sectors Impacting Market Trends Leading the Declines A noticeable drop in market values was driven by several...

Continue Reading
Medline Celebrated for Innovation in Respiratory Care Solutions

Updated Category News Views 180

Medline secured the prestigious Zenith Award from the American Association for Respiratory Care (AARC) in 2024, marking a significant moment for traders and healthcare pros alike. This award wasn’t just handed out; it was earned by only eight companies out of over 300 nominees. The kind of spotlight that draws attention can shake up market sentiments. Why Medline Stood...

Continue Reading